Who has invested in Promentis Pharmaceuticals?

OrbiMed, F-Prime Capital Partners, Aisling Capital, Black Pearl GmbH, Golden Angel Network are named among the investors backing Promentis Pharmaceuticals.

Promentis Pharmaceuticals Funding: $31M Raised, Series C

Promentis Pharmaceuticals funding overview

Promentis Pharmaceuticals is based in Milwaukee. Promentis Pharmaceuticals has raised $31M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in March 2017. The round record for Promentis Pharmaceuticals runs through 2017; nothing later has been disclosed. Investors on record include OrbiMed, F-Prime Capital Partners, Aisling Capital, Black Pearl GmbH, Golden Angel Network. 5 distinct backers are named across the disclosed rounds.

Promentis Pharmaceuticals at a glance

Total raised: $31M
Latest round: Series C
Latest round date: March 2017
Headquarters: Milwaukee
Notable investors: OrbiMed, F-Prime Capital Partners, Aisling Capital, Black Pearl GmbH, Golden Angel Network

Frequently asked about Promentis Pharmaceuticals funding

How much has Promentis Pharmaceuticals raised?: Promentis Pharmaceuticals has raised $31M in total disclosed funding across the rounds on record.
Who has invested in Promentis Pharmaceuticals?: OrbiMed, F-Prime Capital Partners, Aisling Capital, Black Pearl GmbH, Golden Angel Network are named among the investors backing Promentis Pharmaceuticals.
What was the latest Promentis Pharmaceuticals funding round?: The most recent disclosed round is a Series C, announced in March 2017.
Where is Promentis Pharmaceuticals based?: Promentis Pharmaceuticals is based in Milwaukee.
When did Promentis Pharmaceuticals last raise?: The last disclosed Promentis Pharmaceuticals round closed in March 2017 at Series C.

Promentis Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Milwaukee below to benchmark round size and investor mix.

Promentis Pharmaceuticals Funding: $31M Raised, Series C

Promentis Pharmaceuticals funding overview

Promentis Pharmaceuticals at a glance

Frequently asked about Promentis Pharmaceuticals funding

Companies related to Promentis Pharmaceuticals (21)

Browse related funding lists (5)